Tumour necrosis factor-α and lymphotoxin-α gene polymorphisms in cystic fibrosis lung disease Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Clinical course of cystic fibrosis lung disease and tumour necrosis factor-β gene polymorphism Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
TNF gene polymorphisms and asthma development in cystic fibrosis patients Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010
Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 522s Year: 2006
Tumour necrosis factor-α polymorphism and ozone-induced lung function change Source: Annual Congress 2003 - Effects of outdoor air pollution in adults Year: 2003
Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene Source: Eur Respir J 2002; 19: 912-918 Year: 2002
Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005
Tumor necrosis factor-α and interleukin-6 gene polymorphisms in pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 520s Year: 2005
Analysis of tumor necrosis factor receptor 1 (TNFR1) polymorphisms in patients with cryptogenic fibrosing alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 411s Year: 2001
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD Source: Eur Respir J 2007; 30: 810-812 Year: 2007
Pulmonary lesions in patients with inflammatory bowel disease – the baseline and under anti-tumor necrosis factor therapy. Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017
Level of tumor necrosis factor-α in induced sputum and TNF-α gene promoter polymorphism in Korean COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 132s Year: 2007
Tumor necrosis factor-α gene polymorphisms in COPD in a Spanish population Source: Eur Respir J 2005; 26: Suppl. 49, 94s Year: 2005
Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis Source: Eur Respir J 2003; 21: 421-428 Year: 2003
Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006
Circulating inflammatory cytokines in adult cystic fibrosis patients Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009
Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002
Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Source: Eur Respir J 2007; 29: 8-10 Year: 2007
Tumor necrosis factor α in chronic pulmonary diseases of children Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002
The relationship of IL-4 cytokine gene polymorphisms, HRCT and histopathological score in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011